Market Indices
Latest News
| ||
| ||
| ||
|
Price Targets
Chris Hoare from New Street issued a price target of $35.00 for AMX on 2026-06-17 12:32:18.The adjusted price target was set to $35.00.At the time of the announcement,
June 17, 2026 AMX -1.44%
from UBS issued a price target of $7.20 for UGP on 2026-06-17 12:19:08.The adjusted price target was set to $7.20.At the time of the announcement, UGP was...
June 17, 2026 UGP -0.11%
from Scotiabank issued a price target of $19.00 for VALE on 2026-06-15 14:10:42.The adjusted price target was set to $19.00.At the time of the announcement, VALE was...
June 15, 2026 VALE -2.82%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| CCM Concord Medical Services | 5.36
14.04% | ||||||||||||||||||
| CPAC Cementos Pacasmayo S.A.A. | 11.94
11.96% | ||||||||||||||||||
| QH Quhuo Limited | 10.44
10.36% | ||||||||||||||||||
| PPBT Purple Biotech Ltd. | 1.79
9.14% | ||||||||||||||||||
| SIMO Silicon Motion Technology | 305.63
8.12% | ||||||||||||||||||
| NNDM Nano Dimension Ltd. | 1.33
7.72% | ||||||||||||||||||
| ATHE Alterity Therapeutics Lim | 4.99
7.20% | ||||||||||||||||||
| BLTE Belite Bio, Inc | 146.81
6.24% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 1.30%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA -1.32%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 TEVA -1.32%